Navigation Links
Novo Nordisk and BGI establish global collaboration framework
Date:3/2/2012

March 2, 2012, Copenhagen, Denmark and Shenzhen, China Novo Nordisk, one of the world's leading companies in diabetes care and BGI, the world's largest genomics organization jointly announced that they have reached an agreement to establish a global collaboration framework, which provides an unprecedented collaborative opportunity for Novo Nordisk and BGI to accelerate their growth, execute their global partnering strategy and support disease research and development efforts. The agreement was signed by Professor Allan Ertmann Karlsen, Corporate and Scientific Vice President of Novo Nordisk and Dr. Ning Li, Director of BGI Europe.

Under the agreement, this collaboration will combine BGI's next generation sequencing platforms and bioinformatics capabilities with Novo Nordisk's expertise and experience in drug development under a global framework. This agreement is enforceable to Novo Nordisk's headquarter in Denmark, international production facilities in seven countries, and its affiliates or regional offices in 75 countries as well as BGI's headquarter in Shenzhen and affiliates worldwide, including BGI-Hong Kong, BGI-Europe, BGI-Americas, among others.

"We appreciate this great opportunity to bring our extensive genomics experience in the collaboration with Novo Nordisk." said Dr. Li, "With the recent opening of our first European Genome Centre in Denmark, we believe it will provide an excellent platform for us and our collaborators, and we are looking forward to establish more collaborations with more partners across Europe and worldwide. "


'/>"/>

Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Page: 1

Related biology news :

1. TET Systems and Novo Nordisk sign license agreement
2. NTU to establish Singapore as Asian hub in complexity science research
3. DFG to establish 4 new research units
4. Weizmann Institute and Max Planck Society establish a joint center for archaeology and anthropology
5. Study establishes importance of tracking diseases associated with illegal wildlife trade
6. Rices Grande-Allen wins AHA Established Investigator Award
7. Malaysian Oil Palm Biomass Center established
8. Iowa State engineers establish national panel to advance a carbon negative economy
9. San Diego Zoo scientists establish cell cultures of endangered frog
10. UC Davis and BGI announce partnership to establish state-of-the-art genome center in Sacramento
11. DFG establishes 12 new research units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: